Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health...

Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009
Health Care Conference on May 13, 2009

CRANBURY, N.J., May 11 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq:
FOLD) today announced that the Company's Chief Operating Officer, Matthew R.
Patterson, will be presenting at the upcoming Bank of America and Merrill
Lynch Conference in New York City. Mr. Patterson's presentation is scheduled
to begin on Wednesday, May 13th at 4:00 p.m. EDT.

Individuals can listen to a live webcast of the presentation by logging on to
the Investors section of the Amicus Therapeutics' Web site,
http://www.amicustherapeutics.com. Participants should allow approximately
five to ten minutes prior to the presentation's start time to visit the site
and download any streaming media software needed to listen to the Internet
webcast. A replay of the webcast will also be available on the Company's Web
site for 30 days.

About Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing novel, oral
therapeutics known as pharmacological chaperones for the treatment of a range
of human genetic diseases. Pharmacological chaperone technology involves the
use of small molecules that selectively bind to and stabilize proteins in
cells, leading to improved protein folding and trafficking, and increased
activity. Amicus is initially targeting lysosomal storage disorders, which are
severe, chronic genetic diseases with unmet medical needs.

SOURCE Amicus Therapeutics

Jenene Thomas of Amicus Therapeutics, +1-609-662-5084,
jthomas@amicustherapeutics.com